Will a breast tumor be visible on a mammogram (X-ray)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Will a Breast Tumor Show Up on an X-ray (Mammogram)?

Yes, breast tumors can show up on mammography (breast X-ray), but mammography detects only 86-91% of breast cancers, meaning it will miss approximately 9-14% of tumors. 1

Detection Rates and Limitations

  • Mammography's sensitivity for detecting breast cancer ranges from 86% to 91% when evaluating palpable breast abnormalities. 1
  • The greatest limitation of mammography is breast tissue density—very dense tissue makes detection of breast cancer difficult, and tumors can be masked by overlapping normal tissue. 1, 2
  • Interval cancers (tumors that appear between screening mammograms) tend to be more aggressive, occur more in younger women, and are of larger tumor size than screen-detected cancers. 3

What Mammography Can Detect

  • Mammography can identify calcifications, masses, architectural distortions, and asymmetries that may represent breast cancer. 1
  • Early stage tumors, including intraductal carcinoma and stage I infiltrating ductal carcinoma, can be detected on mammograms, with calcifications being the most common finding. 4
  • Tumors with tubular histology or high percentage of in situ components (≥50%) are more likely to be detected by screening mammography. 3

Tumors More Likely to Be Missed

  • Tumors with lobular histology (odds ratio 1.9) or mucinous histology (odds ratio 5.5) are more likely to be missed by mammography and surface between screening examinations. 3
  • Rapidly proliferating, high-grade tumors with high mitotic count (odds ratio 2.9) or high Ki-67 expression (odds ratio 2.3) are more likely to be interval-detected rather than screen-detected. 3
  • Tumors with high histologic grade (odds ratio 2.1), high nuclear grade (odds ratio 2.0), or negative estrogen receptor status (odds ratio 1.8) are associated with interval detection. 3

Critical Clinical Approach

The addition of ultrasound to mammography detects 93-100% of cancers that are occult on mammography, and when both mammography and ultrasound are negative or benign, the negative predictive value is very high at more than 97%. 1

  • For women ≥40 years with a palpable mass, diagnostic mammography should be performed first, followed by targeted ultrasound regardless of mammography results. 5
  • For women <30 years, proceed directly to targeted breast ultrasound as the initial study, as breast cancer incidence is <1% in this age group and most benign lesions are not visualized on mammography. 5, 6

Important Caveats

  • A negative mammogram should never deter biopsy of a clinically suspicious mass—negative imaging evaluation should never overrule a strongly suspicious finding on physical examination. 1, 2
  • Any highly suspicious breast mass detected by imaging or palpation should undergo biopsy unless there are exceptional clinical circumstances. 1
  • Digital breast tomosynthesis (DBT) can address some limitations of standard mammography by decreasing the lesion-masking effect of overlapping tissue, with specificity as high as 98% when re-staging suspicious findings. 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Mammography and breast cancer screening.

The Surgical clinics of North America, 1990

Research

Screening mammography: value in women 35-39 years old.

AJR. American journal of roentgenology, 1993

Guideline

Evaluation of a Palpable Breast Lump

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Breast Imaging in Young Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.